At the news
? NEUTRALIMPACT 1/10 6-K filed Jun 16, 2026 at 15:37 ET
Genmab filed a 6-K reporting a de minimis capital increase of 185 shares (DKK 0.2 million proceeds) from employee warrant exercises, representing less than 0.001% of share capital. This is a routine administrative event with no material impact on the company's financials or operations.
- Capital increase of 185 shares at DKK 1,334.50 per share
- Proceeds of approximately DKK 0.2 million
- Represents less than 0.001% of Genmab's share capital
- Total share capital after increase: DKK 62,353,252 (62,353,252 shares)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access